1672-8629
2007 Issue 6
..............page:385-386
..............page:379-384
Three Cases of Adverse Reaction Induced by Asarone for Injection
WANG Hai-yan;LI Guo-qing
WANG Hai-yan;LI Guo-qing
..............page:377-378
The Apocalypse of FDA Post-market Risk Management of Medical Product
ZHU Mei-na;LI Ye
ZHU Mei-na;LI Ye
..............page:374-376
Analysis of 147 Cases on Adverse Drug Reaction of Gatifloxacin
CUI Ran;WANG Jian-hua
CUI Ran;WANG Jian-hua
..............page:370-373
An analysis of adverse drug reactions of psychotropic drugs in 575 cases
XU Zuo-guo;ZHANG Shao-dong;SONG Yu-fen;WANG Rui-fen;CONG Juan
XU Zuo-guo;ZHANG Shao-dong;SONG Yu-fen;WANG Rui-fen;CONG Juan
..............page:365-369
Study on Data Mining of Adverse Drug Reaction Induced by Heartleaf Houttuynia Herb Injection
WU Jia-rui;ZHANG Bing
WU Jia-rui;ZHANG Bing
..............page:360-364,369
Analysis of ADRs of Traditional Chinese Medicine Injection and Signal Detection
WANG Yue;WU Shu-yi;XU Hou-ming;YU Bo-yang;XIAO Shi-ying
WANG Yue;WU Shu-yi;XU Hou-ming;YU Bo-yang;XIAO Shi-ying
..............page:335-337,347
Strengthening the Monitoring of the Medical Devices Recall Notices and to Improving the Supervision Ability of the Post-Marketing Medical Devices
CHEN Liang;ZHANG Su-min;ZHANG Cheng-xu;WU Zhi-ang
CHEN Liang;ZHANG Su-min;ZHANG Cheng-xu;WU Zhi-ang
..............page:332-334
Study on Adverse Events following Immunization of Influenza Vaccination
DONG Duo;JIN Shao-hong;LIANG Xiao-feng;ZHANG Cheng-xu;LI Xin-ling;CHEN Yi-xin;TIAN Chun-hua;LIU Cui-li;SHEN Lu
DONG Duo;JIN Shao-hong;LIANG Xiao-feng;ZHANG Cheng-xu;LI Xin-ling;CHEN Yi-xin;TIAN Chun-hua;LIU Cui-li;SHEN Lu
..............page:328-331
NCAR-the Platform for MDAE Information Exchange
ZHANG Su-min
ZHANG Su-min
..............page:325-327,351
Adverse Drug Reaction Information Bulletin and Risk Management on Drugs
CHEN Yi-xin;TIAN Chun-hua
CHEN Yi-xin;TIAN Chun-hua
..............page:321-324,331
The ADR Analysis of Potassium Dehydroandrograpolide Succinate Injection
GAO Tian;HE Yan;YANG Juan;LUO Qun-ying
GAO Tian;HE Yan;YANG Juan;LUO Qun-ying
..............page:356-359
Discussion of the Quality Risk Management in Pharmaceutical Manufacture Process
LIU Shu-Lin;ZHANG Yi-en;HAO Xiao-fang;LIANG Shu-chen;HAN Yuan;ZHAO Jian;JIN Shu-hui
LIU Shu-Lin;ZHANG Yi-en;HAO Xiao-fang;LIANG Shu-chen;HAN Yuan;ZHAO Jian;JIN Shu-hui
..............page:352-355
Discussion on the Effects of Pharmacovigilance in the Hospital Pharmaceutical Management
CAO Xiu-qin;SONG Jin-bo
CAO Xiu-qin;SONG Jin-bo
..............page:348-351
Discussion on the Application of Pharmacovigilance in Drug Reevaluation
YAN Zhan-Jun;FAN Yan
YAN Zhan-Jun;FAN Yan
..............page:344-347
Investigation of Information Communication in Adverse Drug Reaction Monitoring
SUN Jun;LU Ye;NI Min
SUN Jun;LU Ye;NI Min
..............page:342-343,378
Investigation and Analysis of Public Cognition for ADR in Tianjin
SONG Li-gang;BAI Hai-peng
SONG Li-gang;BAI Hai-peng
..............page:338-341